Mobile Doctor App 'Shouji Kanbing' Files IPO Prospectus Amid Daily Issuance of Over 1,000 E-Prescriptions

“Mobile Doctor” is a service under Beijing Haojia Network Technology Co., Ltd., which was established in July 2014. The service was officially launched in July 2015, one year after the company’s founding. Currently, the “Mobile Doctor” app has integrated a comprehensive model encompassing “consultation, prescription, medication purchase, and reimbursement.” It issues an average of over 1,000 electronic prescriptions per day, with more than 3,000 types of medications available for delivery.

When using the service, users can choose to consult with an online on-duty physician or select another doctor of their choice for a consultation via the app, based on their medical condition and needs. After conducting a video consultation, the physician can issue an electronic prescription, which holds the same validity as a paper prescription issued in a hospital. Patients not only receive a diagnosis but can also place orders for medications directly within the app based on the prescription and have the drugs delivered to their doorstep. Furthermore, mobile healthcare services are already covered by medical insurance in Henan and Shandong provinces, while negotiations for insurance reimbursement approval in other provinces are actively underway.

“Mobile Healthcare” business is primarily conducted through hospitals and pharmaceutical logistics companies under the China Hospital Group.

In 2004, Zhonghua Hospital Group was incorporated in the Cayman Islands. Hu Chuanping serves as the Chairman of the Group, and Zhou Yu is the co-founder. The group is dedicated to hospital investment and mergers and acquisitions in China. It is reported that, to date, Zhonghua Hospital Group has successfully invested in and restructured 42 public people’s hospitals and enterprise-affiliated hospitals in China, with these facilities primarily concentrated in the Henan and Shandong regions.

In addition to the 42 hospitals it has invested in, China Hospital Group also owns three pharmaceutical logistics companies, including Henan Haihua Pharmaceutical Logistics Co., Ltd. The company’s B2B pharmaceutical website, “Haoyaowang” (Good Medicine Net), is a large-scale pharmaceutical trading platform focused on modern pharmaceutical logistics and drug procurement. It holds national third-party pharmaceutical logistics and distribution qualifications and possesses the Class B Certificate for Internet Drug Transaction Services issued by the Henan Food and Drug Administration. Offline, it operates a pharmaceutical warehouse and logistics base covering more than 68,000 square meters, equipped with advanced Transportation Management System (TMS), Warehouse Management System (WMS), and Enterprise Resource Planning (ERP) information management systems. Reportedly, all medications for the 42 hospitals under China Hospital Group and its partner medical institutions are supplied by this company. Furthermore, it also provides pharmaceutical logistics services for the “Mobile Doctor Visit” APP.

Zhou Yu introduced that for patients in Henan and Shandong provinces, electronic prescriptions issued via mobile video consultations are nominally provided by several hospitals under the China Hospital Group, including Puyang Oilfield General Hospital, a Grade 3A hospital. Patients can use these electronic prescriptions to purchase medications at pharmacies or place online orders with home delivery options. Both models allow for reimbursement through medical insurance channels.

Doctors on the "Mobile Doctor" app are primarily from Grade A tertiary hospitals in major cities such as Beijing, Shanghai, and Guangzhou, as well as from hospitals within the group. Additionally, the platform has established a team of 43 on-duty doctors: 41 are from the group’s internal Grade A tertiary hospitals and all hold general practitioner qualifications, while the other two are licensed practitioners in Hong Kong and Australia, respectively, mainly serving foreigners living and working in China. Currently, text-and-image consultations with on-duty doctors on "Mobile Doctor" are free of charge, video consultations with on-duty doctors cost RMB 20, and service fees for specialist doctors range from RMB 20, 30, and 50 to RMB 200.Patient-PaidConsultation fees are fully retained by the physician., the platform does not charge fees from it, but primarily derives its revenue fromPharmaceuticalsProfitability。

How to Ensure the Safety of Doctors and Patients?Zhou Yu stated that the hospital group underpinning the “Mobile Healthcare” platform, along with its established security management system, canEnable physicians to legally and compliantly provide telemedicine services to patients。

The platform provides enrolled physicians with medical insurance coverage equivalent to that offered by traditional brick-and-mortar hospitals. In addition to conventional medical malpractice liability insurance, the platform plans to introduce “Multi-Practice Site Medical Malpractice Liability Insurance” for physicians, thereby ensuring that doctors and specialists practicing on the platform can provide consultations with peace of mind.

In the management of prescription drugs, for patients seeking to obtain prescriptions through "mobile consultations," general practitioners providing these services must first review photos of existing prescriptions or diagnostic certificates issued by other accredited hospitals (tentatively defined as Tier 2 Grade A or higher), or verify that the patient is a follow-up case previously seen in person. Physicians must conduct a thorough inquiry into the patient's condition, akin to an in-hospital consultation. Prescriptions are restricted to common chronic diseases (such as hypertension and diabetes); generally, no prescriptions are issued for initial diagnoses.

Prescriptions issued by physicians via the app do not include substances restricted and regulated by national drug regulatory authorities, such as Schedule I psychotropic drugs, recreational drugs, or addictive substances. This includes antidepressants like Cymbalta, Prozac, and sertraline, as well as medications such as Viagra and Cialis. Physicians will not accommodate patient requests to prescribe these restricted or controlled medications.

To standardize physicians’ consultation practices and maintain harmonious doctor–patient relationships, the “Mobile Healthcare” platform regularly pushes guidance to both doctors and patients on improving consultation efficiency. By incorporating the U.S. Telemedicine Practice Guidelines, the platform ensures that doctors and patients are informed of pre-consultation requirements, thereby fostering mutual understanding through friendly communication. Additionally, the platform periodically compiles and shares common patient complaints and feedback with physicians, enabling them to better understand the psychological needs of diverse patients, respond more effectively to special circumstances, and ultimately enhance patient satisfaction.

It is understood that the users of “Mobile Healthcare” mainly come from the B-side, and the teamDirectly with some large state-owned enterprisesand the hospitalSign the agreement, providing annuallySigned through B-end channelsEmployee, Patients can enjoy more benefits，For example, subscribed users can receive a certain amount of cashback when ordering medications through the "Mobile Doctor Consultation" service.Most enrolled users reside in regions with relatively underdeveloped medical resources. “Mobile Healthcare” organizes contracted physicians to conduct local health examinations, provide diagnosis and treatment, and arrange post-consultation follow-up services for these users. According to Zhou Yu, this approach has helped the platform surpass 10 million enrolled patients nationwide, with users primarily distributed across provinces and municipalities such as Henan, Shandong, Hebei, Jiangsu, Inner Mongolia, and Xinjiang.

The “Mobile Healthcare” team currently has a total of 60 members, including approximately 40 in the technical team.